This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Amgen, AT&T and Yum! Brands Lead Today's Earnings: Crunching the Numbers

NEW YORK (TheStreet) -- In this post we profile 10 companies that report their quarterly earnings reports after the closing bell this afternoon. When we profile stocks pre-earnings, we include two "Crunching the Numbers' tables. The first table covers the technicals and the second table covers analysts' earnings-per-share estimates and our value levels, pivots and risky levels.

Let's start with individual profiles then get into the tables that follow.


Amgen (AMGN) ($117.02, up 2.6% YTD): Analysts expect the biotech giant to report earnings per share of $1.81 after the closing bell today. The stock traded to an all-time intraday high at $128.96 on March 21, then traded as low as $111.39 on April 14, just below its 200-day simple moving average at $114.91.

The weekly chart is negative, with its five-week modified moving average at $118.11. Weekly and semiannual value levels are $114.88 and $102.54, with a monthly risky level at $126.11.

Cree (CREE) ($57.56, down 7.9% YTD): Analysts expect the maker of semiconductors that enhance solid-state lighting to report earnings per share of 29 cents after the closing bell today. The stock has been below its 200-day SMA at $61.68 since Feb. 27, trading as low as $53.83 on April 15.

The weekly chart is negative but oversold, with its five-week MMA at $57.59. Annual and weekly value levels are $55.64 and $55.25 with semiannual and quarterly risky levels at $64.80 and $66.04.

Discover Financial (DFS) ($56.77, up 1.5% YTD): Analysts expect the credit card company to report earnings per share of $1.25 after the closing bell today. The stock set an all-time intraday high at $60.00 on March 21, then traded as low as $54.35 on April 11, staying above its 200-day SMA at $53.13.

The weekly chart shifts to negative on a close this week below its five-week MMA at $56.78. Semiannual value levels are $55.50 and $50.77, with weekly and monthly risky levels at $58.04 and $58.56.

Gilead Sciences (GILD) ($71.60, down 4.7% YTD): Analysts expect the biopharmaceutical company to report earnings per share of 75 cents after the closing bell today. The stock set an all-time intraday high at $84.88 on Feb. 25, then traded as low as $63.50 on April 11, below its 200-day SMA at $69.47.

The weekly chart is negative, with its five-week MMA at $72.32. The chart pattern clearly shows a bubble that has popped. Weekly and semiannual value levels are $63.25 and $63.19, with quarterly and monthly risky levels at $78.02 and $82.91.

1 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,445.53 -117.77 -0.71%
S&P 500 1,920.20 -10.47 -0.54%
NASDAQ 4,334.6890 -35.0840 -0.80%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs